fibrosis

News

More claudin buzz as Alentis raises $105m

Swiss biotech Alentis Therapeutics has raised a very respectable $105 million in third-round financing that will be dedicated to the development of its Claudin-targeting d

News

Redx joins with Jounce to create cancer, fibrosis biotech

UK biotech Redx Pharma and US-based Jounce Therapeutics have agreed to merge, pooling their resources to create a new company dedicated to the development of small-molecul

Events

Partner Content

6th Antifibrotic Drug Development Summit

As the only industry-led forum providing biopharma with the insights necessary to make strategic and scientific decisions on their fibrosis pipeline, the 6th

News

PureTech challenges Roche's Esbriet in head-to-head IPF tria...

Roche's idiopathic pulmonary fibrosis (IPF) therapy Esbriet is already being squeezed by its main rival in the market, and could come under renewed pressure if another competitor from PureT

News

Boehringer invests again in AI diagnosis specialist Brainomi...

UK digital health company Brainomix has raised £16 million ($21.5 million) that will be used to extend the use of its artificial intelligence-based medical imaging software for stroke to ne

Events